Authors:
FULTON J
JONESON T
VOLLE D
CHAIKA O
BARSAGI D
LEWIS R
Citation: J. Fulton et al., KINASE SUPPRESSOR OF RAS INHIBITS THE ACTIVATION OF ERK MAP KINASE BYINSULIN, ACTIVATED RAS, AND RAS EFFECTORS, Diabetes, 47, 1998, pp. 81-81
Citation: J. Boehm et al., ANTI-APOPTOTIC SIGNALING BY A CSF-1 RECEPTOR INSULIN-RECEPTOR CHIMERAWITH A JUXTAMEMBRANE DELETION, Diabetes, 47, 1998, pp. 1306-1306
Citation: O. Chaika et al., MUTATION OF TYROSINE-960 WITHIN THE INSULIN-RECEPTOR JUXTAMEMBRANE DOMAIN IMPAIRS GLUCOSE-TRANSPORT, BUT DOES NOT INHIBIT LIGAND-MEDIATED PHOSPHORYLATION OF IRS-2 IN 3T3-L1-ADIPOCYTES, Diabetes, 46, 1997, pp. 5-5
Citation: R. Lewis et al., DELETION OF THE INSULIN-RECEPTOR JUXTAMEMBRANE DOMAIN DOES NOT INHIBIT LIGAND-MEDIATED ADIPOCYTE DIFFERENTIATION, Diabetes, 45, 1996, pp. 160-160
Citation: O. Chaika et al., EXPRESSION OF A CSF-1 RECEPTOR INSULIN-RECEPTOR CHIMERA PERMITS CSF-1-DEPENDENT DIFFERENTIATION OF 3T3-L1 PREADIPOCYTES, Diabetes, 44, 1995, pp. 103-103